Name the two main categories of etiologies of aplastic anemia

Aplastic anemia is due to the diminished or absent of these cells.

Mr ST has just been diagnosed with aplastic anemia. The hematologist informed him he does not need any treatment, just monitoring of his CBC. Mt ST's aplastic anemia is classified as this.

ATG requires premedication with these two drugs

The maximum dose of eltrombopag in aplastic anemia is this dose

Aplastic anemia has been reported in patients who have undergone this organ transplantation

Petechiae is a sign of low amounts of this blood cell.

Ms AB is an only child. Her hematologist would start her on this therapy for her newly diagnosed aplastic anemia.

This drug used in the treatment of aplastic anemia can cause serum sickness

The primary end point were defined according to hematologic responses and toxic effect at this number of weeks

This drug can cause reversible or irreversible aplastic anemia

Aplastic anemia is classified in these three categories

Mr WS has been informed that her brother is a comptible donor. She will be admitted in the hospital next week for this kind of transplant for the treatment of her aplastic anemia,

Either of these two drugs can be used as prophylaxis for serum sickness

The response rate (%) of eltrombopag in at least one lineage 12 weeks after initiation of eltrombopag is this

The risk of aplastic anemia increases when the dose of this drug is between 200 and 450mg

Any patient who has an ANC of less than this amount would be diagnosed as having very severe aplstic anemia

Ms AB return 2 years later with recurrence of her aplastic anemia. Her hematologist starts her on the combination of cyclosporine and this drug

Cyclosporine doses are adjusted to maintain blood trough level between these two levels

9 of the 11 patients with response to eltrombopag no longer required this type of transfusion

Name any one of the congenital disorders that are associated with higher risk of aplastic anemia

These are the two main prognostic indicators of aplastic anemia.

The hematologist wants to prescribe this drug, which is the only oral drug approved as monotherapy for the treatment of severe aplastic anemia with insufficient response to immunosuppressive therapy

Cyclosporine is stopped after this amount of time if the patient maintains the hematologic response.

The mean count of this cell at baseline was found to be predictive of response to eltrombopag